Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Vidarabine Phosphate

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Vidarabine Phosphate:

Pubmed Logo
Genzyme takes Campath bet.
PURPOSE: The phase II CLL2H trial evaluated safety and efficacy of...
30th September, 2009
Nat Biotechnol. 2009 Jun;27(6):498.
DOI Direct Link
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
Nucleoside analogs are rationally designed anticancer agents that disrupt...
4th August, 2009
Genzyme Corporation, Framingham, Int J Oncol. 2009 May;34(5):1329-40.
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
The purpose of this study was to determine the effect of alemtuzumab on...
18th June, 2009
Section of Hematology/Oncology, University of Chicago, Chicago, Illinois Biol Blood Marrow Transplant. 2009 May;15(5):610-7.
DOI Direct Link
Collision induced dissociation studies of alkali metal adducts of tetracyclines and antiviral agents by electrospray ionization, hydrogen/deuterium exchange and multiple stage mass spectrometry.
The collision induced dissociation (CID) mass spectra were obtained for...
17th December, 2008
Department of Exploratory Medicinal Sciences, Pfizer Global Research and Eur J Mass Spectrom (Chichester, Eng). 2008;14(5):281-97.
DOI Direct Link
High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia.
A multicentre single-arm study testing the efficacy and toxicity of the...
17th December, 2008
Department of Haematology, Claude Huriez University Hospital, Lille, Br J Haematol. 2008 Sep;143(1):54-9. Epub 2008 Aug 15.
DOI Direct Link

View more research publications.

Press Releases About Vidarabine Phosphate:

BioPortfolio Logo
Reportlinker Adds European Market for Dental Implants and Final Abutments 2009 (17 Countries) 17th November, 2009 Reportlinker
NEW YORK, Nov. 17 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. European Market for Dental Implants and Final Abutments 2009 (17 Countries
Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego 26th October, 2009 Keryx Biopharmaceuticals, Inc.
NEW YORK, Oct. 26 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that an abstract related to the clinical data of the 55-patient Phase 2 high-dose study of
Perrigo Reports Record Third Quarter 7th May, 2009 Perrigo Company
Perrigo Company (from continuing operations, in thousands, except per share amounts) Third Quarter Nine Months
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel 17th March, 2009 Perrigo Company
ALLEGAN, Mich., March 17 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Cobrek Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application
Shire Announces Launch of FOSRENOL(R) in Japan 11th March, 2009
DUBLIN, March 11 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announces the Japanese launch of FOSRENOL(R) (lanthanum carbonate), which is

BioNews Results for Vidarabine Phosphate:

RSS Logo
BioPortfolio Logo
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Bionity.com:  Nov 21 2009 5:27AM Matching: phosphate
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
PharmaceuticalProcessing:  Nov 20 2009 8:23PM Matching: phosphate
Genzyme Announces Results Of Phase 2/3 Trial Of Advanced Phosphate Binder
Medical News Today:  Nov 20 2009 4:43PM Matching: phosphate
Medical News: Genzyme Announces Results Of Phase 2/3 Trial Of Advanced Phosphate Binder
BioFind:  Nov 20 2009 12:57PM Matching: phosphate
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
MDLinx:  Nov 19 2009 11:21AM Matching: phosphate
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Vidarabine Phosphate Patents:

USPTO Logo
US Patent No.Title
7615539 Nucleic acid-lipophilic conjugates
7153510 Recombinant vesiculoviruses and their uses
7101573 Simethicone solid oral dosage form
6890743 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses
6682761 Water-insoluble drug particle process

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Vidarabine Phosphate scientists - we have details of around 38 individuals working on Vidarabine Phosphate .


This page has been viewed 289 times
Recent Search Terms used to find this page: vidarabine | Vidarabine-Distribution | Vidarabine | vidarabine drug development | vidarabine drug development | Vidarabine Phosphate HPLC | vidarabine phosphate | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Vidarabine Phosphate across BioPortfolio, or for Vidarabine Phosphate Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.